Abingdon

ABDX.L

Tags: GB Healthcare Medical - Diagnostics & Research

Abingdon Health Plc Price (ABDX.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

304,732,264

(0.3558)%

Market Cap of Abingdon (ABDX.L)

Market cap:

As of , ABDX.L has a market cap of . This makes ABDX.L the 1038th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally,... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $6.5-11.75
Market Cap 13.55M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

ceo: Mr. Chris Henry Francis Yates
IPO Date: December, 15, 2020
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 84

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: